False-Positive Results with a Commercially Available West Nile Virus Immunoglobulin M Assay — United States, 2008

In September 2008, CDC, the Food and Drug Administration (FDA), and state health departments began a nationwide investigation into an increase in false-positive test results obtained with a commercially available West Nile virus (WNV) immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	MMWR. Morbidity and mortality weekly report 2009-05, Vol.58 (17), p.458-460
Hauptverfasser:	Neitzel, D.F, Kemperman, M.M, Semple, S, Wong, S, Hallisey, J, Feist, M.A, Miller, T.K, Chung, W.M, Hojvat, S, Summers, P, Lanciotti, R.S, Panella, A.J, Laven, J, Kosoy, O, Lehman, J.A, Nasci, R.S, Fischer, M, Staples, J.E, Zielinski-Gutierrez, E, Janusz, K.B
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Demographic aspects Diagnosis Disease vectors Enzyme-linked immunosorbent assay Enzyme-Linked Immunosorbent Assay - standards Epidemiology False Positive Reactions Fluorescent Antibody Technique, Direct - standards Government services Humans Immunoglobulin M - analysis Infections Laboratories - standards Medical care Methods Nervous system diseases Notifiable diseases Population Surveillance Public health Quality management Specimens United States West Nile fever West Nile Fever - diagnosis West Nile virus West Nile virus - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!